期刊文献+

CHEK2单核苷酸多态性与乳腺癌的易感性 被引量:1

Relationship between CHEK2 mutation and the risk of breast cancer
原文传递
导出
摘要 目的研究细胞周期检测点激酶2(CHEK2)基因启动子单核苷酸多态性与女性乳腺癌易感性的相关性。方法采用病例.对照研究方法,运用等位基因扩增-聚合酶链反应(ASA—PCR)方法,结合琼脂糖凝胶电泳技术,分析200例乳腺癌患者(病例组)和200例非乳腺癌患者(对照组)CHEK2基因rs17878974和rsl7883911基因型的分布,并比较不同基因型与乳腺癌易感性的关系。结果CHEK2基因rs17878974基因位点C/C、C/T、T/T基因型频率在病例组与对照组中比较差异未见统计学意义(X2=0.041,P=0.839);T、C基因频率在病例组与对照组间比较差异未见统计学意义(x。=0.377,P=0.539)。rs17883911基因位点A/A、A/G、G/G基因频率在病例组和对照组间比较差异有统计学意义(x2=21.122,P〈0.001);G、A基因频率在病例组及对照组间比较差异有统计学意义(x2=13.115,P〈0.001,oR=1.804,95%CI:1.308~2.488)。结论CHEK2基因rsl7878974多态性不能增加女性乳腺癌的易感性,rs17878974多态性可能增加女性乳腺癌的易感性。 Objective To study the relationship between the single nucleotide polymorphism in the promoter of the cell-cycle-checkpoint kinase 2 (CHEK2) gene and the susceptibility of breast cancer in female population. Methods A case-control study was conducted. The distribution of polymorphisms rs17878974 and rs17883911 in CHEK2 gene were'analyzed using allele specific amplification(ASA) and agarose gel eleetrophoresis in 200 patients With breast cancer and 200 samples of normal controls. Results No significant differealce Was found in the genotypes( C/C, C/T and T/T) at rs17878974 be- tween the breast cancer group and the control group(x2 =0. 041, P =0. 839) , and there was no signifi- cant difference in the T and C gene frequency between the two groups ( X2 = 0. 377, P = 0. 539). There was significant difference in the genotypes (A/A, A/G and G/G) at rs17883911 between the breast cancer group and the control group(x2 =21. 122, P 〈0. 001 ), there was significant difference in the G and A gene frequency between the breast cancer group and the control group (X2 = 13. 115, P 〈0. 001, OR = 1. 804,95% CI: 1. 308-2. 488 ). Conclusions The single nucleotide polymorphism of CHEK2 gene at rs17878974 position is unlikely to be associated with susceptibility of breast cancer in women. But the single nucleotide polymorphism of CHEK2 gene at rs17878974 position is probably correlated with the in- cidence of breast cancer in women.
出处 《中国实用医刊》 2016年第21期11-14,共4页 Chinese Journal of Practical Medicine
关键词 乳腺癌 细胞周期检测点激酶2 单核苷酸多态性 等位基因 Breast cancer Cell-cycle-checkpoint kinase 2 Single nucleotide polymorphism Alleles
  • 相关文献

参考文献6

二级参考文献102

  • 1宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.中国上海家族性乳腺癌BRCA1和BRCA2基因的突变[J].中华医学遗传学杂志,2006,23(1):27-31. 被引量:29
  • 2管晓翔,陈龙邦.组蛋白乙酰化修饰在基因表达调控中的作用机制[J].中华肿瘤防治杂志,2007,14(4):307-310. 被引量:22
  • 3Einarsdottir K, Humphreys K, Bonnard C, et al. Linkage disequilib- rium mapping of CHEK2: common variation and breast cancer risk [J]. PLoS Med, 2006,3(6):e168.
  • 4Caligo MA, Agata S, Aceto G, et al. The CHEK2 c. 1100delC muta- tion plays an irrelevant role in breast cancer predisposition in Italy [J]. Hum Murat, 2004,24(1):100-101.
  • 5Zhang B.RhoGDP dissociation inhibitors as potential targets for anti-cancer treatment[J].Drug Resist Updat,2006,9(3):134-141.
  • 6Etienne-Manneville S,Hall A.RhoGTPases in cell biology[J].Na-ture,2002,420(6916):629-635.
  • 7Leffers H,Nielsen MS,Andersen AH,et al.Identification oftwo human RhoGDP dissociation inhibitor proteins whose over-expression leads to disruption of the actin cytoskeleton[J].ExpCell Res,1993,209(2):165-174.
  • 8Zhou X,Suto S,Ota T,et al.Nuclear translocation of cleaved LyGDIdissociated from rho and roC during p53-dependent ionizing radiation-induced thymic apoptosis in vitro[J].Radiat Res,2004,162(3):287-295.
  • 9Zhang Y,Zhang B.D4-GDI,a Rho GTPase regulator,promotesbreast cancer cell invasiveness[J].Cancer Res,2006,66(11):5592-5598.
  • 10Cho HJ,Baek KE,Park SM,et al.RhoGDI2expression is as-sociated with tumor growth and malignant progression of gastriccancer[J].Human Cancer Biology,2009,15(8):2612-2619.

共引文献10

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部